Volume 96, Issue 12 pp. 3402-3418

Use of manometric temperature measurement (MTM) and SMART™ freeze dryer technology for development of an optimized freeze-drying cycle

Henning Gieseler

Corresponding Author

Henning Gieseler

School of Pharmacy, University of Connecticut, 69 North Eagleville Road, Storrs, Connecticut 06269

Department of Pharmaceutics, University of Erlangen, Cauerstrasse 4, Erlangen, Germany

School of Pharmacy, University of Connecticut, 69 North Eagleville Road, Storrs, Connecticut 06269 Telephone: +49-9131-8529556; Fax: +49-9131-8529545Search for more papers by this author
Tony Kramer

Tony Kramer

Parenteral Center of Emphasis (PCoE), Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340

Search for more papers by this author
Michael J. Pikal

Michael J. Pikal

School of Pharmacy, University of Connecticut, 69 North Eagleville Road, Storrs, Connecticut 06269

Search for more papers by this author
First published: 12 September 2007
Citations: 14

Abstract

This report provides, for the first time, a summary of experiments using SMART™ Freeze Dryer technology during a 9 month testing period. A minimum ice sublimation area of about 300 cm2 for the laboratory freeze dryer, with a chamber volume 107.5 L, was found consistent with data obtained during previous experiments with a smaller freeze dryer (52 L). Good reproducibility was found for cycle design with different type of excipients, formulations, and vials used. SMART™ primary drying end point estimates were accurate in the majority of the experiments, but showed an over prediction of primary cycle time when the product did not fully achieve steady state conditions before the first MTM measurement was performed. Product resistance data for 5% sucrose mixtures at varying fill depths were very reproducible. Product temperature determined by SMART™ was typically in good agreement with thermocouple data through about 50% of primary drying time, with significant deviations occurring near the end of primary drying, as expected, but showing a bias much earlier in primary drying for high solid content formulations (16.6% Pfizer product) and polyvinylpyrrolidone (40 kDa) likely due to water “re-adsorption” by the amorphous product during the MTM test. © 2007 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 96: 3402–3418, 2007

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.